Product Information
RISEDRONATE SODIUM 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.4976 per EA under NDC 33342010707. Its NADAC has been published 127 times since Mar 20, 2024.
FDA first approved this application on Dec 9, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342010707
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RISEDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203533FDA Approved
12/9/2015
TE Code
AB
On Market Since
12/9/2015
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 5 MG TABLET has been published 127 times since Mar 20, 2024, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4976 per EA |
|---|---|
| All-time high | $1.7003 (Dec 10, 2025) |
| All-time low | $1.0715 (Feb 19, 2025) |
| 52-week high | $1.7003 |
| 52-week low | $1.3486 |
| Median price | $1.4700 |
| Average price | $1.4627 |
| Largest weekly change | -14.2% (Jan 22, 2025) |
| Weeks tracked | 127 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $1.4976 per EA (NDC 33342010707), effective Aug 19, 2026.
How has the price of RISEDRONATE SODIUM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 5 MG TABLET has declined 9.7%. It has been tracked across 127 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 5 MG TABLET?
Since Mar 20, 2024, the NADAC for RISEDRONATE SODIUM 5 MG TABLET has ranged from a low of $1.0715 (Feb 19, 2025) to a high of $1.7003 (Dec 10, 2025), with a median of $1.4700 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RISEDRONATE SODIUM 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 5 MG TABLET?
RISEDRONATE SODIUM 5 MG TABLET (NDC 33342010707) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.